Internal Medicine, Endocrinology, Diabetes, & Metabolism · Summerfield, FL
NPI
1245265941
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
10250 SE 167th Place Rd, Suite 5-1
Summerfield, FL, 34491
Phone (352) 307-9925
Groups this clinician bills Medicare through
Medicare paid, 2024
$215K
7,627 services
Medicare patients, 2024
746
Average age 76
Drug cost, 2024
$4.0M
8,310 prescriptions
Company payments, 2025
$832
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Prabhat K Tandon was code J0897 (injection, denosumab, 1 mg), 1,201 times for 13 patients. In total Prabhat K Tandon billed 7,627 services in 60 codes, and Medicare paid $215K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-01-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,201 | 13 | $20.02 | $24K |
| 99214 Office E&M - Established | Office | 972 | 565 | $88.35 | $86K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 694 | 488 | $12.54 | $8,702 |
| 36415 Venipuncture Blood Collection | Office | 648 | 361 | $8.65 | $5,605 |
| 80053 Clinical Chemistry | Office | 492 | 314 | $10.35 | $5,092 |
| 84443 Clinical Chemistry | Office | 476 | 311 | $16.46 | $7,835 |
| 85025 Blood Count | Office | 470 | 306 | $7.61 | $3,577 |
| 84439 Clinical Chemistry | Office | 449 | 298 | $8.84 | $3,969 |
| 83021 Blood Count | Office | 360 | 211 | $17.70 | $6,372 |
| 95251 Test - Miscellaneous | Office | 208 | 113 | $26.32 | $5,474 |
| 99204 Office E&M - New | Office | 174 | 174 | $114.48 | $20K |
| 82043 Clinical Chemistry | Office | 155 | 124 | $5.66 | $877 |
| 82570 Clinical Chemistry | Office | 154 | 123 | $5.08 | $782 |
| 82607 Clinical Chemistry | Office | 128 | 120 | $14.78 | $1,892 |
| 82746 Clinical Chemistry | Office | 111 | 102 | $14.41 | $1,600 |
By year: 2022 $307K for 10,238 services; 2023 $289K for 9,572 services; 2024 $215K for 7,627 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 648 | 361 | $8.65 | $5,605 |
| 80053 Clinical Chemistry | 492 | 314 | $10.35 | $5,092 |
| 84443 Clinical Chemistry | 476 | 311 | $16.46 | $7,835 |
| 85025 Blood Count | 470 | 306 | $7.61 | $3,577 |
| 84439 Clinical Chemistry | 449 | 298 | $8.84 | $3,969 |
| 83021 Blood Count | 360 | 211 | $17.70 | $6,372 |
| 82043 Clinical Chemistry | 155 | 124 | $5.66 | $877 |
| 82570 Clinical Chemistry | 154 | 123 | $5.08 | $782 |
| 82607 Clinical Chemistry | 128 | 120 | $14.78 | $1,892 |
| 82746 Clinical Chemistry | 111 | 102 | $14.41 | $1,600 |
Medicare prescription drug claims, 2024
In 2024, the drug Prabhat K Tandon prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,003 prescriptions and refills. In total Prabhat K Tandon wrote 8,310 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,003 | 2,864 | 312 | $11K |
| Ozempic Semaglutide | 691 | 1,105 | 159 | $1.0M |
| Metformin Hcl Generic | 525 | 1,440 | 188 | $3,988 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 507 | 1,277 | 194 | $88K |
| Metformin Hcl Er Metformin Hcl | 337 | 888 | 112 | $3,458 |
| Jardiance Empagliflozin | 316 | 734 | 93 | $423K |
| Mounjaro Tirzepatide | 250 | 355 | 59 | $376K |
| Novolog Flexpen Insulin Aspart | 237 | 552 | 95 | $77K |
| Methimazole Generic | 226 | 649 | 73 | $3,052 |
| Synthroid Levothyroxine Sodium | 221 | 541 | 60 | $17K |
| Farxiga Dapagliflozin Propanediol | 219 | 500 | 65 | $273K |
| Pioglitazone Hcl Generic | 214 | 563 | 73 | $3,116 |
| Glipizide Generic | 168 | 493 | 60 | $1,735 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 167 | 447 | 71 | $27K |
| Humulin R U-500 Kwikpen Insulin Regular, Human | 165 | 225 | 31 | $276K |
Brand drugs: 5,160 claims; generic drugs: 2,499 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Prabhat K Tandon $832 ($832 in general payments such as food, travel and fees) from 20 companies. The largest payer was Corcept Therapeutics with $103.
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics CORT | 5 | $103 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $77.68 |
| Medtronic, Inc. MDT | 2 | $74.88 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $73.67 |
| Eisai Inc. 4523.T | 2 | $51.55 |
| Teva Pharmaceuticals USA, Inc. TEVA | 2 | $51.32 |
| UCB, Inc. UCB.BR | 2 | $48.71 |
| Merck Sharp & Dohme LLC MRK | 2 | $45.17 |
| Boston Scientific Corporation BSX | 1 | $32.36 |
| Beta Bionics, Inc. BBNX | 1 | $32.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.